AVD AMERICAN VANGUARD CORP
Agricultural Chemicals · NYSE · SEC CIK 5981 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.8%
TTM net income YoY46.6%
TTM EPS YoY47.5%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin28.4%
Operating margin-5.7%
Net margin-12.0%
FCF margin-2.5%
EBITDA margin-5.8%
Returns
ROE-31.2%
ROA-9.1%
ROIC (approx.)-6.1%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets75.4%
Debt / equity1.64x
Current ratio2.02x
Interest coverage-0.96x
Cash quality & payout
Operating cash flow / net income0.11x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $515.11M | $547.31M | $579.37M | $609.62M | $557.68M |
| Cost of revenue | $367.55M | $426.99M | $400.21M | $417.23M | $386.95M |
| Gross profit | $147.56M | $120.32M | $179.16M | $192.39M | $170.72M |
| R&D expense | $23.16M | $32.66M | $38.02M | $31.82M | $28.86M |
| SG&A expense | $110.63M | $119.63M | $116.89M | $119.92M | $111.09M |
| Operating income | -$28.30M | -$101.56M | $23.30M | $40.65M | $30.95M |
| Interest expense | $18.47M | $16.55M | $12.64M | $3.95M | $3.69M |
| Pretax income | -$47.20M | -$120.46M | $10.30M | $35.97M | $27.14M |
| Income tax | $2.68M | $5.88M | $2.78M | $8.56M | $8.17M |
| Net income | -$49.88M | -$126.34M | $7.52M | $27.40M | $18.59M |
| EBITDA | -$23.04M | -$96.40M | $29.89M | $49.56M | $40.18M |
| EPS (basic) | -1.75 | -4.50 | 0.27 | 0.94 | 0.62 |
| EPS (diluted) | -1.75 | -4.50 | 0.26 | 0.92 | 0.61 |
| Dividends declared per share | — | 0.06 | 0.12 | 0.10 | 0.08 |
| Weighted avg. shares (diluted) | 28.43M | 28.06M | 28.53M | 29.87M | 30.41M |
| Balance sheet | |||||
| Cash & equivalents | $12.43M | $12.51M | $11.42M | $20.33M | $16.29M |
| Receivables | $160.51M | $169.74M | $182.61M | $156.49M | $149.33M |
| Inventory | $176.03M | $179.29M | $219.55M | $184.19M | $154.31M |
| Current assets | $370.52M | $378.89M | $432.02M | $388.57M | $342.00M |
| PP&E, net | $53.04M | $58.17M | $74.56M | $70.91M | $66.11M |
| Goodwill | $0 | $19.70M | $51.20M | $47.01M | $46.26M |
| Intangibles | $138.75M | $150.50M | $172.51M | $184.66M | $197.84M |
| Total assets | $596.54M | $636.72M | $767.55M | $726.31M | $694.16M |
| Current liabilities | $209.45M | $232.35M | $230.50M | $266.60M | $223.06M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $174.00M | $147.33M | $138.90M | $51.48M | $52.24M |
| Total debt | $174.00M | $147.33M | $138.90M | $51.48M | $52.24M |
| Total liabilities | $404.14M | $403.61M | $397.54M | $356.33M | $321.42M |
| Shareholders' equity | $192.40M | $233.11M | $370.01M | $369.98M | $372.74M |
| Net debt | $161.57M | $134.82M | $127.48M | $31.15M | $35.95M |
| Cash flow statement | |||||
| Operating cash flow | -$21.19M | $3.92M | -$58.75M | $57.10M | $86.36M |
| Capital expenditure | $3.92M | $7.28M | $11.88M | $13.26M | $9.52M |
| Free cash flow | -$25.11M | -$3.36M | -$70.63M | $43.84M | $76.84M |
| Investing cash flow | -$3.61M | -$6.62M | -$17.02M | -$14.47M | -$20.04M |
| Financing cash flow | $23.70M | $4.54M | $66.74M | -$38.26M | -$65.87M |
| Depreciation & amortization | $5.25M | $5.16M | $6.60M | $8.91M | $9.23M |
| Stock-based compensation | $2.02M | $4.41M | $6.14M | $5.68M | $6.88M |
| Dividends paid | $0 | $2.51M | $3.38M | $2.79M | $2.38M |
| Share buybacks | $0 | $0 | $15.54M | $34.00M | $4.58M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.